MFP
CBST

Michael F. Price’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Michael F. Price’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-182,500
Closed -$8.81M – 92
2013
Q2 		$8.81M Buy
+182,500
New +$8.97M 1.18% 30

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Michael F. Price's CBST Position: Q3 2013 in Review

Michael F. Price sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2013, closing a stake of 182,500 shares — an estimated $8.81M sold.

Michael F. Price first reported a position in CBST in Q2 2013 and held it in 1 quarter. The position peaked at $8.81M in Q2 2013. 271 funds tracked by Wall St. Rank hold CBST as of Q3 2013.

  • Michael F. Price reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Michael F. Price sold 182,500 CUBIST PHARMACEUTICALS INC shares in Q3 2013, an estimated $8.81M.
  • Michael F. Price first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Michael F. Price's CUBIST PHARMACEUTICALS INC position peaked at $8.81M in Q2 2013.
  • 271 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2013.

Based on Michael F. Price's 13F filing for Q3 2013, filed 12 Nov 2013.